Determination and Validation of Lung EpiCheck®: A Multianalyte Assay for Lung Cancer Prediction. A Case-Control Study
Status: Recruiting
Location: See all (31) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
View:
• Current or past smokers, with at least 20 pack-years
• Subjects with either A high suspicion for lung cancer, with planned surgery to establish a definitive diagnosis within 60 days after date of blood collection OR treatment naive lung cancer patients
⁃ \- Current or past smokers, with at least 20 pack-years, undergoing LDCT for lung cancer screening
Locations
United States
California
Scripps Memorial Hospital
RECRUITING
Encinitas
Colorado
Centura Health
RECRUITING
Lakewood
Connecticut
VA Connecticut Healthcare System
RECRUITING
West Haven
Florida
Orlando Health, Inc.
RECRUITING
Orlando
Sarasota Memorial Hospital
RECRUITING
Sarasota
Kentucky
St. Elizabeth Edgewood Hospital
RECRUITING
Edgewood
Norton Cancer Institute
RECRUITING
Louisville
Owensboro Health
RECRUITING
Owensboro
Massachusetts
Lahey Hospital and Medical Center
RECRUITING
Burlington
Maryland
Johns Hopkins Medical Center
RECRUITING
Baltimore
Minnesota
University of Minnesota Health
RECRUITING
Minneapolis
Missouri
Harry S. Truman Memorial Veterans' Hospital
RECRUITING
Columbia
Washington University in St. Louis
RECRUITING
St Louis
North Carolina
The University of North Carolina
RECRUITING
Chapel Hill
Duke University
RECRUITING
Durham
Durham VA Health Care System
RECRUITING
Durham
W.G. (Bill) Hefner VA Medical Center
RECRUITING
Salisbury
Novant Health Cancer Research
RECRUITING
Winston-salem
New York
Northwell Health
RECRUITING
New Hyde Park
University of Rochester
RECRUITING
Rochester
Ohio
Summa Health
RECRUITING
Akron
Cleveland Clinic Foundation
RECRUITING
Cleveland
Pennsylvania
Thomas Jefferson University
RECRUITING
Philadelphia
South Carolina
Medical University of South Carolina (MUSC)
RECRUITING
Charleston
Ralph H. Johnson VA Medical Center
RECRUITING
Charleston
Tennessee
Baptist Cancer Center
RECRUITING
Memphis
Texas
Michael E. DeBakey VA Medical Center
RECRUITING
Houston
Other Locations
Canada
University of Calgary
RECRUITING
Calgary
McGill University Health Centre
RECRUITING
Montreal
University Health Network
RECRUITING
Toronto
Vancouver General Hospital/The University of British Columbia
RECRUITING
Vancouver
Contact Information
Primary
Rahda Duttagupta, PhD
radha@nucleix.com
8582833388
Time Frame
Start Date: 2021-09-17
Estimated Completion Date: 2025-09
Participants
Target number of participants: 5000
Treatments
Cases Series
Subjects with confirmed lung cancer diagnosis
Screening Series
Subjects undergoing LDCT for lung cancer screening
Related Therapeutic Areas
Sponsors
Leads: Nucleix Ltd.